2004: Foundation of STX-Med with the mission to research and develop practical innovations in the field of electronics and bio-electronics for use on humans.
The STX-Med project was formed from the collaboration of two founders who are experts in bio-engineering; one is an engineer and the son of a physician, while the other is a physician and the son of an engineer.
Pierre-Yves MULLER :
Pierre François RIGAUX :
The two founders have worked together for 20 years to develop several unique and innovative medical devices in the fields of ultrasound, neuro-stimulation, electromyography and various forms of bio-signal analysis. The pair have extensive expertise in recording the electrical signals emitted by the human body that act electrically on the nerves and muscles.
2005: Launch of CEFALY project®
Cefaly® project: external cranial neurostimulation. Cânaial neurostimulation was existing only with invasive devices. STX-Med decided to start lancer a series of technical and clinical to develop a new technology: making feasible non-invasive cranila neurostimulation.
2007: Workflows control & certifications
2008: Launch of Cefaly® & new research programs
2009: Presentation of Cefaly® at the Arab Health trade fair in Dubai.
As already experienced at the Medica trade fair, Cefaly® enjoyed tremendous success and firm distribution contacts were established with several countries in Middle East.
2009: Collaboration with 5 University for the evaluation of Cefaly® safety and efficacy for migraine prevention.
Two phase II clinical trials are implemented to demonstrate Cefaly® safety and efficacy in 2 indications: sedative effect and migraine prevention.
2010: Certification ISO13485 CMD CAS (for Canada)
Launch of Cefaly® in Canada and implementation of the renting test system in several European countries.
2011: BMC Neurology peer review publishes about the VIGILANCE clinical trial which demonstrates the sedative effect of Cefaly® on the central nervous system
2012: Start of TRADONI research project about chronic pain treatment.
STX-Med establishes a partnership with Liege University and the research department of the Walloon region for the launch of a research project having the objective the development of an "electronic aspirin".
2012: STX-Med winner of Grand Prix Wallonie Export
STX-Med wins the Grand Prix Wallonia Export in the young company category because of its rapid export sales since 2010.
2012: Launch of Cefaly® on the French market with a press conference in Paris
2013: Start of clinical trial for the treatment of primary chronic insomnia in France.
Start of collaboration with Prof Léger of Paris and Prof Paquereau in Poitiers for the implementation of a control clinical trial about a non-drug treatment of primary chronic insomnia.